Name: Secondary Findings in Genomic Research (Translational and Applied Genomics) (en Inglés)
SKU: 56725193
Price: 3209.76 MXN
Availability: InStock
Author: Langanke Martin,Erdmann Pia,Brothers Kyle B.
ISBN: 9780128165492

portada Secondary Findings in Genomic Research (Translational and Applied Genomics) (en Inglés)

Secondary Findings in Genomic Research (Translational and Applied Genomics) (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Langanke Martin,Erdmann Pia,Brothers Kyle B.

Idioma

Inglés

N° páginas

244

Encuadernación

Tapa Blanda

ISBN13

9780128165492

N° edición

Secondary Findings in Genomic Research (Translational and Applied Genomics) (en Inglés)

Langanke Martin,Erdmann Pia,Brothers Kyle B. (Autor) · Academic Press · Tapa Blanda

Libro Nuevo Importado

Envío: 19 a 25 días háb.

$ 5,349.60$ 3,209.76

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 3,209.76

¡Envío Gratis! Llega entre el 02 Oct y el 13 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Secondary Findings in Genomic Research (Translational and Applied Genomics) (en Inglés)"

Secondary Findings in Genomic Research offers a single, highly accessible resource on interpreting, managing and disclosing secondary findings in genomic research. With chapters written by experts in the field, this book is the first to concisely explain the ethical and practical issues raised by secondary genomics findings for a multi and interdisciplinary audience of genomic researchers, translational scientists, clinicians, medical students, genetic counselors, ethicists, legal experts and law students, public policy specialists and regulators. Contributors from Europe, North America, and Asia effectively synthesize perspectives from a spectrum of different scientific, societal, and global contexts, and offer pragmatic approaches to a range of topics, including oversight, governance and policy surrounding secondary genomic results, criteria for identifying results for return, communication and consent, stakeholders' attitudes and perspectives, disclosing results, and clinical, patient-centered protocols.